文献速递血液净化与透析水电解质与酸碱

腹膜透析治疗加巴喷丁中毒:加巴喷丁清除率评估

Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance.
PubMed 文献 · Am J Kidney Dis · 2017-07-01

本文报告一例长期腹膜透析患者发生加巴喷丁中毒,接受持续自动化循环腹膜透析治疗。每2小时2L交换时,表观消除半衰期为41.33小时,明显短于无肾功能时报告的132小时;症状在透析约36小时后完全缓解。腹膜透析对加巴喷丁的清除率估计为尿素清除率的94%。

要点

  • 强化腹膜透析可提供接近尿素的加巴喷丁清除率
  • 每2小时2L交换时表观消除半衰期为41.33小时
  • 腹膜透析是有效但缓慢的加巴喷丁中毒治疗方式

核心结论

  • 强化腹膜透析对加巴喷丁的清除率约为尿素的94%,是治疗加巴喷丁过量与中毒的有效但缓慢的方法。

研究设计与样本

  • 个案报告:一例长期腹膜透析患者发生加巴喷丁中毒,接受持续自动化循环腹膜透析治疗。

主要发现

  • 每2小时2L交换时,加巴喷丁表观消除半衰期为41.33小时,明显短于无肾功能时报告的132小时。
  • 患者加巴喷丁中毒症状逐渐改善,透析约36小时后完全缓解。
  • 腹膜透析对加巴喷丁的清除率估计为尿素清除率的94%。

关键数值与推荐

  • 每2小时2L交换条件下,表观消除半衰期为41.33小时。
  • 无肾功能时报告的消除半衰期为132小时。
  • 腹膜透析加巴喷丁清除率估计为尿素清除率的94%。

临床怎么用

  • 对腹膜透析患者发生加巴喷丁中毒,可考虑强化持续自动化循环腹膜透析清除药物,但起效较慢。

局限性

  • 为单例个案报告,结论需更多研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gabapentin is almost exclusively cleared by the kidney and thus presents challenges in patients with kidney failure. Gabapentin is known to be effectively cleared by hemodialysis, but the efficiency of clearance by peritoneal dialysis (PD) has not been previously described. We report a case of gabapentin toxicity in a patient on long-term PD who was treated with continuous automated cycling PD. We find that continuous PD provides significant clearance of gabapentin. With 2-L exchanges every 2 hours, we document an apparent elimination half-life of 41.33 hours, which is substantially shorter than the reported elimination half-life of 132 hours in the absence of kidney function. Further, our patient's symptoms of gabapentin toxicity gradually improved and had fully resolved after about 36 hours of dialysis. Gabapentin clearance by PD was estimated at 94% of urea clearance. We conclude that intensive PD provides gabapentin clearance that approximates that of urea and is an effective but slow method to treat gabapentin overdose and toxicity.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Ibrahim H, Oman Z, Schuelke M, et al. Treatment of Gabapentin Toxicity With Peritoneal Dialysis: Assessment of Gabapentin Clearance. Am J Kidney Dis. 2017. PMID: 28676198. doi:10.1053/j.ajkd.2017.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。